WKYMVm, a strong FPR2 agonist, was recently reported to have multiple effects on cell differentiation.25 As a major FPR2 agonist, WKYMVm exhibits anti‐inflammatory and anti‐tumour effects. The gene discussed is FPR2; the disease is neoplasm.